G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn… Read more
G Medical Innovations Holdings Ltd (GMVDF) - Net Assets
Latest net assets as of March 2023: $-4.57 Million USD
Based on the latest financial reports, G Medical Innovations Holdings Ltd (GMVDF) has net assets worth $-4.57 Million USD as of March 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.83 Million) and total liabilities ($9.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.57 Million |
| % of Total Assets | -94.74% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 113.5 |
G Medical Innovations Holdings Ltd - Net Assets Trend (2015–2022)
This chart illustrates how G Medical Innovations Holdings Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for G Medical Innovations Holdings Ltd (2015–2022)
The table below shows the annual net assets of G Medical Innovations Holdings Ltd from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-4.57 Million | -62.55% |
| 2021-12-31 | $-2.81 Million | +4.65% |
| 2020-12-31 | $-2.95 Million | +70.14% |
| 2019-12-31 | $-9.88 Million | -281.31% |
| 2018-12-31 | $-2.59 Million | -119.61% |
| 2017-12-31 | $13.21 Million | +107.39% |
| 2016-12-31 | $6.37 Million | +519.26% |
| 2015-12-31 | $-1.52 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to G Medical Innovations Holdings Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11327100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.83 Million | % |
| Other Comprehensive Income | $1.50 Million | % |
| Other Components | $101.57 Million | % |
| Total Equity | $-7.35 Million | 100.00% |
G Medical Innovations Holdings Ltd Competitors by Market Cap
The table below lists competitors of G Medical Innovations Holdings Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Blackrock World Mining Trust Plc
LSE:BRWM
|
$1.07K |
|
musicMagpie PLC
LSE:MMAG
|
$1.07K |
|
R I L Property PLC
CM:RILN0000
|
$1.07K |
|
Engro Polymer & Chemicals Ltd
KAR:EPCL
|
$1.08K |
|
Third Bench Inc.
PINK:THBD
|
$1.07K |
|
ENSEVAL PUTERA MEGA
MU:FEK
|
$1.07K |
|
CHEUK NANG (HLDGS) (CQH3.SG)
STU:CQH3
|
$1.07K |
|
Lead Data Inc
TW:2443
|
$1.07K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in G Medical Innovations Holdings Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -6,031,000 to -7,353,000, a change of -1,322,000.
- Net loss of 24,629,000 reduced equity.
- Share repurchases of 121,000 reduced equity.
- New share issuances of 3,442,000 increased equity.
- Other factors increased equity by 19,986,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-24.63 Million | -334.95% |
| Share Repurchases | $121.00K | -1.65% |
| Share Issuances | $3.44 Million | +46.81% |
| Other Changes | $19.99 Million | +271.81% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares G Medical Innovations Holdings Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $-1.13 | $0.00 | x |
| 2016-12-31 | $0.09 | $0.00 | x |
| 2017-12-31 | $6.36 | $0.00 | x |
| 2018-12-31 | $-3.34 | $0.00 | x |
| 2019-12-31 | $-6.04 | $0.00 | x |
| 2020-12-31 | $-29.98 | $0.00 | x |
| 2021-12-31 | $-18.59 | $0.00 | x |
| 2022-12-31 | $-10.20 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently G Medical Innovations Holdings Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -557.22%
- • Asset Turnover: 0.92x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-45.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.84 Million |
| 2017 | -318.39% | -24822.94% | 0.01x | 2.53x | $-27.91 Million |
| 2018 | 0.00% | -554.41% | 0.22x | 0.00x | $-16.32 Million |
| 2019 | 0.00% | -280.66% | 0.63x | 0.00x | $-14.17 Million |
| 2020 | 0.00% | -255.84% | 0.90x | 0.00x | $-11.91 Million |
| 2021 | 0.00% | -297.48% | 0.47x | 0.00x | $-14.15 Million |
| 2022 | 0.00% | -557.22% | 0.92x | 0.00x | $-23.89 Million |
Industry Comparison
This section compares G Medical Innovations Holdings Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| G Medical Innovations Holdings Ltd (GMVDF) | $-4.57 Million | 0.00% | N/A | $1.07K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |